Kent and Medway Cancer Alliance (KMCA) is one of eight cancer alliances to participate in the Galleri-GRAIL clinical trial. 

The trial aims to prove whether the Galleri-GRAIL test is effective in diagnosing up to 50 types of cancer by looking for DNA markers in the blood. 

The trial completed in Kent and Medway in June 2024.

Patients from across Kent and Medway between the ages of 50 and 77 were invited at random by NHS Digital, based on their GP registration.

Participants were invited for an annual blood test within the GRAIL mobile unit, which visited towns across Kent and Medway on a programmed basis throughout the three years of the trial.

Each participant had three blood tests in total, at approximately the same time each year between 2022 and 2024. 

Registration for new participants has now closed. 

For any future updates about the trial, please visit the NHS-Galleri website.

Research

If you are interested in in other research that is recruiting at the moment visit Be Part of Research

Worried about symptoms? 

If you are worried that you have symptoms of cancer, you should contact your doctor as soon as possible.

This should be the case even if you are taking part in research.

Screening 

If you are invited for NHS Cancer Screening (for breast, bowel or cervical cancer) or you are asked to attend a lung health check, it is very important that you consider taking part in these, even if you are part of the GRAIL research.

Cancer screening is proven to save lives. Find out more about cancer screening in Kent and Medway.